Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acid, ADC, amino, atopic, BAC, bankruptcy, bifurcate, binding, Biopharma, bispecific, Chancery, clearance, compound, conjugate, constituted, convenience, counsel, domain, duty, enrichment, equitable, excessive, hundred, innopharma, instrument, margin, marketplace, monospecific, nominal, peer, pertaining, phototherapy, plaque, prioritized, reengineer, reply, sequence, spot, Sutro, toxicology, transparency, twenty, ulcerative, undisclosed, unjust, unpublished, waste
Removed:
repurchased, usage
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 31.1 Certification by the Company's Chief Executive Officer
- 31.2 Certification by the Company's Chief Financial Officer
- 32.1 Certification by the Company's Chief Executive Officer Pursuant to Section 1350
- 32.2 Certification by the Company's Chief Financial Officer Pursuant to Section 1350
- Download Excel data file
- View Excel data file
Related press release
CELG similar filings
Filing view
External links